Chronic kidney disease (CKD) is the gradual decrease in renal function. Currently available
biomarkers are effective only in detecting late stage CKD. Biomarkers of early stage CKD …

Proteomics has long been considered an ideal platform, and urine an ideal source for
biomarker discovery in human autoimmune kidney diseases. A number of studies have …

Serum is an ideal biological sample that contains an archive of information due to the
presence of a variety of proteins released by diseased tissue, and serum proteomics has …

Proteomics methodologies hold great promise in basic renal research and clinical
nephrology. The classical approach for proteomic analysis couples two‐dimensional gel …

The simplest definition of a biomarker is a molecule that indicates an alteration in physiology
from normal. A more practical definition of a biomarker would require clinical utility of this …

Low-density lipoprotein. Alanine transaminase. Troponin I. Alpha-1-antitrypsin. Clinicians
throughout the world rely on standardized laboratory reference values of proteins to …

Proteogenomics is a multi-omics research field that has the aim to efficiently integrate
genomics, transcriptomics and proteomics. With this approach it is possible to identify new …

The technology platforms for proteome analysis have advanced considerably over the last
few years. Due to these improvements the number of studies on the analysis of the …

Clinical proteomics, the application of proteome analysis to serve a clinical purpose,
represents a major field in the area of proteome research. Over 1000 manuscripts on this …

An increasing number of patients suffering from renal diseases and limitations in standard
diagnostic and therapeutic approaches has created an intense interest in applying …